pic).
The coordinating minister for the National Covid-19 Immunisation Programme told Berita Harian on Friday (April 30) that they would only need to make an appointment for logistics purposes, because it involves special vaccination centres (PPV).
“The AstraZeneca vaccine will only be given to voluntary applicants following the government s announcement that it will not be used at the normal PPV.
“These voluntary applicants are the ones who are aware of all the facts surrounding the vaccine and will undergo a health assessment before receiving their dose, ” he was quoted as saying.
On Wednesday (April 28), the government announced that it will offer the AstraZeneca Covid-19 vaccine on a “first come, first serve” basis to the public in Kuala Lumpur and Selangor.
AstraZeneca vaccine to go to those who volunteer - KJ
Modified8:36 am
-
COVID-19 | AstraZeneca vaccines against Covid-19 will only be used on a voluntary basis in Malaysia, according to Khairy Jamaluddin.
The science, technology and innovation minister told a presser today that the decision was made as certain quarters were worried about its possible side-effects regardless of data that shows it is safe. We have agreed that a proactive measure is to be taken, where the AstraZeneca vaccine can still be used, and at the same time address the concerns that some people have (over its use), although their fear is not based on science.
PUTRAJAYA: The number of blood clot or thrombosis cases after receiving the AstraZeneca Covid-19 vaccine jab is low and rare, said the Health Ministry.
Monday, 26 Apr 2021 10:52 PM MYT
Dr Kalaiarasu M Periasamy said based on data from the Medicines and Healthcare Products Regulatory Agency (MHRA) and the European Medicines Agency (EMA), there have been 168 cases of thrombosis detected worldwide since March and, during that period, about 21.6 million individuals worldwide had received the AstraZeneca vaccine jab. Reuters pic
Subscribe to our Telegram channel for the latest updates on news you need to know.
PUTRAJAYA, April 26 The number of blood clot or thrombosis cases after receiving the AstraZeneca Covid-19 vaccine jab is low and rare, said the Health Ministry’s (MOH) Covid-19 Vaccine Candidate Selection Sub-Committee (JKKPCV) chairman, Dr Kalaiarasu M Periasamy.
(pic).
Dr Adham said the Health Ministry was convinced, after a thorough study and assessment, that the benefits of the vaccine outweigh its negatives. The AstraZeneca vaccine is safe to be used for all and it is effective. We will begin using the vaccine on those aged 60 years and above (in Phase Two of the National Covid-19 Immunisation Programme), said Dr Adham at a press conference here on Monday (April 26).
Dr Adham said with the addition of AstraZeneca in Malaysia s Covid-19 vaccine line-up, the country s supply issues could be resolved. We now have many candidates. We already have Pfizer and Sinovac.